Four capsules as a single dose initially, another four capsules after eight hours, then four capsules twice daily (morning and evening) for two days (total 24 capsules over three days). Take with a high-fat meal/drink.
Treatment of most forms of malaria, including resistant types.
Artemether and lumefantrine (artemisinin-based combination therapy) work together to eliminate the malaria parasite.
Yes. Hypersensitivity to ingredients, patients taking drugs metabolized by CYP2D6, and patients with electrolyte imbalances.
Not for use in the first trimester of pregnancy, effectiveness in severe malaria not evaluated, encourage normal eating, repeat dose if vomiting within one hour.
Symptomatic and supportive therapy, including ECG and blood potassium monitoring.
Below 30°C in a cool, dry, and dark place. Protect from light. Keep out of reach of children.
Artemether: rapid absorption, peak concentration at 2 hours, half-life ~2 hours. Lumefantrine: absorption after a lag time of up to 2 hours, peak concentration at 6-8 hours, half-life 3-6 days. Both are highly protein-bound.
Pregnancy: Not in first trimester; second/third trimester only if benefit outweighs risk. Breastfeeding: Not recommended during treatment and for at least one week after, unless benefit outweighs risk.
Other antimalarials, CYP450 3A4 inhibitors, protease inhibitors, and antiretroviral drugs. Consult a healthcare professional.
Blister packs of 12, 18, and 24 soft gelatin capsules. #24 pack is one full adult treatment course.
20mg Artemether and 120mg Lumefantrine, plus excipients and approved colours.